MedImmune

Feb 27, 2020

Global H1N1 Vaccines Industry Insights, 2020 to 2025 - Featuring Profiles of MedImmune, Sanofi Pasteur, GlaxoSmithKline, Abbott Labs, CSL Limited, Pfizer, and More

Sep 12, 2019

Visiongain Report Claims There is Huge Potential Within the $4.9bn Influenza Vaccines Market

Dec 07, 2018

Global Human Vaccines Strategic Business Report 2018: Analysis & Forecast 2016-2024 - Market Trends & Issues

Oct 31, 2018

Nasal Spray Vaccines Back in Play for 2018-2019 Flu Season

Aug 09, 2018

$32 Billion-Dollar Market for Vaccines: Report

Jul 02, 2018

Global Influenza Vaccines Market Outlook 2018-2028 - Visiongain Report

May 24, 2018

Global Intranasal Drug Delivery Markets, 2016-2018 & 2024 - Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application

Apr 25, 2018

Influenza Market, 2022 - Vaccines, Therapeutics and Diagnostics

Apr 24, 2018

Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors

Apr 02, 2018

Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products

Feb 28, 2018

Viela Bio Spins Out of MedImmune; Launches with Up to $250 Million Series A Financing from Investor Consortium Led by Boyu Capital, 6 Dimensions Capital, and Hillhouse Capital

Feb 05, 2018

Drug Delivery Technologies Market Forecast 2018-2028